AI

Surgio Health and DARVIS Partner to Deliver Transformative Healthcare Solutions Through AI and Machine Learning Technology

Surgio | December 01, 2021

AI and Machine Learning Technology for Healthcare

Surgio Health, a leading healthcare software platform targeting instrument tracking and optimization solutions, has partnered with DARVIS (Data Analytic Real-World Visual Intelligence System), a pioneer in the digitization of hospital logistics, hygiene, and process documentation through AI technology. Together, the two are diving into creating innovative instrument tracking and optimization solutions utilizing optical recognition and machine learning technology.

DARVIS is a productivity as a service platform (PaaS) that digitizes objects and processes through AI-powered computer vision technology, enabling it to provide real-time analysis of environments and situations. With the use of computer vision technology, healthcare providers can now easily track objects such as surgical instruments, no matter how small. This allows for tracking and optimization down to the instrument level without the need to individually tag each item. 

Surgio Health is a software as a service platform (SaaS) that provides a fully integrated digital transformation of surgical asset management and optimization for the operating room (OR) and sterile processing department (SPD). With Surgio, facilities can easily locate surgical instruments, ensure proper sterilization steps are taken, coordinate with vendors for loaned and consigned instrument sets, and use interactive analytics to reduce costs and improve productivity.

Using DARVIS's computer vision technology, the two will be able to incorporate the use of AI tracking cameras with Surgio's innovative and in-depth tracking software. With the creation of this partnership, the OR and SPD will be able to manage and optimize their sterilization costs, staffing models, and case readiness.

"DARVIS is thrilled to join forces with Surgio to bring the next age of innovation to healthcare. Our Inventory Tracker platform adds visibility to Surgio's robust existing tracking software. The Inventory Tracker solution can track surgery kits and scopes throughout the equipment's entire lifecycle. This directly translates to immediate boosts in efficiency standards and cost savings." - Jan Schlueter, COO, DARVIS

"Surgio is very excited to partner with DARVIS for the development of transformative Artificial Intelligence through optical recognition and machine learning solutions. Together we will bring actionable data insights that provide real-time visibility and predictability of surgical equipment and staffing optimization to the OR and SPD departments." 

Chris J. Stewart, CEO, Surgio Health

Instrument level tracking becomes even easier with machine learning. Eliminating the need to tag individual instruments makes implementation painless and cost-effective for any hospital system. Surgio and DARVIS will begin by tracking endoscopes, which are often one of the most challenging—and costly—instruments to track and sterilize effectively, with undetectable bioburden frequently remaining in tough-to-clean areas. Through DARVIS's visual tracking system, Surgio can ensure that these scopes are systematically sterilized properly, without additional work being placed on employees.

Together, DARVIS and Surgio want to eliminate patient safety risks and unnecessary processing costs related to sterilization, while simplifying process and workflow for hospitals and their staff. Currently, the two companies plan to release their first partnership solution in 2022.

About Surgio

Surgio Health is a surgical instrument management technology partner for healthcare facilities and medical device manufacturers. Surgio delivers an innovative suite of solutions that drive alignment between OR, sterile processing department (SPD), surgeons, and vendors to lower costs, mitigate risk, and improve efficiencies. Our surgical instrument tracking & optimization, vendor performance management, and manufacturer & distributor asset management solutions follow HIPAA guidelines and are EHR/ERP integrated. Founded in 2015, the company is based in Scottsdale, Arizona. 

About DARVIS

DARVIS (Data Analytic Real-World Visual Intelligence System) is a pioneer in the digitization of hospital logistics, hygiene, and process documentation through AI technology. DARVIS solutions help transform hospitals and healthcare organizations into intelligent autonomous environments that enable healthcare professionals to deliver better and safer patient-centric care. Founded in 2015, the company is based in Nashville, Tennessee. 

Spotlight

Watch to see how changes in technology are helping to prevent graft-versus-host disease in cancer patients who receive bone marrow or stem cell transplants.


Other News
Digital Healthcare

ClosedLoop Introduces Data Science Products for Value-Based Healthcare

ClosedLoop | September 20, 2023

ClosedLoop, a prominent healthcare data science platform, has formally introduced two novel data science solutions. These solutions, namely, ACO-Predict and Evaluate, are crafted to assist healthcare organizations in the comprehensive analysis, assessment, ongoing surveillance, and enhancement of their programs, with the objectives of minimizing adverse events, enhancing health outcomes, and curtailing expenditures. ClosedLoop's offering, ACO-Predict, marks the healthcare sector's inaugural no-cost AI-powered solution for population health risk stratification. It harnesses the same algorithms that propelled ClosedLoop to garner fame in the 2021 CMS AI Challenge and earned the Best in KLAS Healthcare AI ranking for 2022 and 2023. When integrated with the updated Beneficiary Claims Data API data feeds from the Centers for Medicare and Medicaid Services, the product furnishes Medicare Accountable Care Organizations with a turnkey risk stratification tool for Complex Care Management programs, all free of charge. Meanwhile, the company's second product, ClosedLoop Evaluate, is a SaaS solution designed to evaluate and continuously monitor the efficacy of intricate population health initiatives over extended durations. Quantifying the impact and ROI of Population Health programs has presented significant challenges. Organizations often need to resort to imprecise pre- and post-assessments or enlist costly consulting firms for one-off outcome research studies to understand the actual effects of their programs. ClosedLoop’s solutions aim to improve healthcare organizations' outcomes and offer essential patient support. Jennifer Zbell, VP of Clinical Analytics at Healthfirst, stated, ClosedLoop provided the quantitative evidence we needed to increase investment in successful programs." She added, "Evaluate gives us the confidence to examine our programs across the board so we can better see what's working, when it's working, and who it's working for. [Source – Business Wire] ClosedLoop Evaluate represents a pioneering industry solution that not only supplants these studies with software-driven evaluations but also facilitates the ongoing assessment of program impact amid evolving programs and populations. Andrew Eye, Co-Founder and CEO of ClosedLoop concluded that success in value-based care hinges on two key aspects: accurate prediction and effective intervention. ACO-Predict delivers AI-powered prediction capabilities to all medicare patients nationwide at no cost, ensuring access to necessary assistance regardless of location or ACO resources. About ClosedLoop ClosedLoop is a dedicated data science platform tailored to the healthcare sector, simplifying the integration of AI technology to enhance outcomes and curtail expenses. Uniquely designed for the healthcare domain, the company merges an intuitive, all-encompassing ML platform with an extensive repository of healthcare-specific functionalities and model templates. Customers leverage ClosedLoop's Explainable AI capabilities to facilitate clinical excellence, streamline operational processes, navigate value-based contracts, and bolster revenue generation in the healthcare industry.

Read More

Health Technology

ShiftKey Extends Its Tech Solutions to Embrace Acute Care Facilities

ShiftKey | September 15, 2023

ShiftKey, a leading technological enterprise at the forefront of reshaping the future of workforce engagement, has officially announced its expansion into acute healthcare facilities. ShiftKey's technology, data resources, and talent marketplace are set to be accessible to acute care facilities in Kansas, Missouri, Tennessee, and Texas. This expansion addresses workforce-related challenges and enhances patients' access to top-tier healthcare services. Furthermore, the technology has already undergone beta testing at acute care facilities in Alabama, Louisiana, Nebraska, New Mexico, South Carolina, and West Virginia. CEO of ShiftKey, Mike Vitek, characterized the company's foray into the acute care sector as a pivotal step in its platform and business development. He emphasized the organization's vantage point on healthcare staffing challenges and expressed optimism regarding the potential alleviation of strain on acute care facilities and healthcare professionals. Meanwhile, Brandon Tappan, Chief Revenue Officer at ShiftKey, added that the escalating workforce challenges confronting healthcare facilities have become an annual trend. The departure of nurses from acute care facilities in large numbers underscores the imperative for a novel approach to address staffing needs within institutions serving vulnerable populations. Integrating ShiftKey's technology into acute care facilities represents establishing an independent healthcare staffing solution. This initiative aims to reinvigorate and safeguard this vital industry by enabling individuals to rejoin the workforce on their terms. About ShiftKey ShiftKey is a technological enterprise dedicated to transforming workforce access and integrity. Employing data and a marketplace model, the company facilitates connections between independent licensed professionals and facilities with workforce requirements. It is pivotal in advancing empowered labor, stability, and solutions for professionals, institutions, and beneficiaries. With a platform encompassing 10,000 healthcare facilities and myriad independently licensed professionals, ShiftKey is one of the foremost leaders in strategic workforce solutions, catalyzing a more sustainable, inclusive, and prosperous workforce economy for the years ahead.

Read More

Health Technology

Crothall and Beyond Clean Revolutionize Sterile Processing Education

Beyond Clean | September 07, 2023

Two prominent entities in the sterile processing industry, Crothall Healthcare and Beyond Clean, have entered into a strategic partnership to develop an innovative educational curriculum specially designed for sterile processing professionals serving in hospitals throughout the United States. This partnership leverages both organizations' collective wealth of knowledge and extensive experience to empower sterile processing professionals with state-of-the-art expertise, enhance patient safety, and elevate the overall benchmarks for sterile processing industry-wide. Afif Escheik, BA, CHL, CER, CIS, CRCST, CST, Regional Director of Operations at Crothall Healthcare, expressed that this partnership will enhance the company's capacity to provide sterile processing professionals with the educational tools necessary to meet and exceed industry standards, reduce errors, and optimize productivity. Crothall's track record of achievement in the field of sterile processing has been founded upon its stringent, data-centric methodologies, which have led to a remarkable enhancement in audit compliance of nearly 90%, a substantial reduction in process errors of up to 50%, and significant productivity gains of up to 62%. Through this collaboration, Crothall intends to incorporate these invaluable insights into developing the forthcoming curriculum. Hank Balch, Founder and President of Beyond Clean, remarked that this partnership will help elevate the standard of sterile processing in the United States, significantly impacting patient safety and quality of service. The collaborative curriculum is adaptable for various care settings, promoting sustainable, high-value care, enhancing patient safety, and reducing errors across the healthcare organization. This partnership signifies a significant step towards a safer and more efficient future in surgical services. About Crothall Healthcare With more than three decades of experience in the healthcare sector, Crothall Healthcare is the foremost provider of patient-centered support services, offering comprehensive solutions tailored to diverse care settings. Its sterile processing services integrate extensive healthcare expertise, clinical rigor, and industry best practices to deliver efficient and highly effective services. About Beyond Clean Beyond Clean is a global expert in sterilizing educational content. The company's unwavering commitment to sterile processing motivates it to empower frontline professionals with essential knowledge, education, and steadfast assistance. It also enables them to uphold impeccable standards and ensure the continuous cleanliness of all instruments.

Read More

Healthcare Analytics

FDA Grants De Novo for Xenex's LightStrike+ UV Robot in Healthcare

Xenex | September 11, 2023

United States Food and Drug Administration (USFDA) has issued a De Novo authorization to Xenex Disinfection Services, Inc. (Xenex) for its LightStrikeTM+ device, an advanced high-intensity, broad-spectrum ultraviolet (UV) light robot. The LightStrike+ devices are designed for microbial reduction on non-critical medical device surfaces in healthcare environments, following manual cleaning and disinfection practices. They are authorized for use in various healthcare settings, including unoccupied operating rooms and hospital rooms. These devices have an impressive track record, with over 1,200 healthcare facilities worldwide employing LightStrike robots for over 37 million cycles. The new LightStrike+ device, capable of microbial reduction in as little as 2 minutes, represents the culmination of over a decade of knowledge accumulation from healthcare facilities' best practices, supported by 45 peer-reviewed studies demonstrating its safety and effectiveness, a portfolio of 193 patents, and unparalleled technical and epidemiological expertise. Dr. Mark 'Tuck' Stibich, Xenex's Founder and Chief Scientific Officer, emphasized the long-standing collaboration with healthcare partners spanning more than a decade to enhance patient safety and public health. As an infectious diseases epidemiologist, Dr. Stibich expressed concern about antibiotic resistance within hospital environments and the potential for FDA authorization to facilitate the broader adoption of the LightStrike+ tool in combating pathogens. Perilous pathogens persist on surfaces within healthcare facilities, notwithstanding diligent manual cleaning endeavors. The LightStrike+ robot employs a xenon lamp to generate high-intensity pulsed UV light, which effectively diminishes the presence of these pathogens on surfaces and plays a pivotal role in interrupting the transmission chain from one patient or healthcare worker to another. Xenex's FDA authorization is substantiated by comprehensive testing conducted on more than 10,000 samples of vegetative bacteria and Clostridiodes difficile (C. diff) spores. This authorization establishes a novel medical device product classification, with the LightStrike+ robot being its inaugural and sole product. It is a landmark in the FDA's regulatory framework for UV robots designed to diminish pathogens on non-porous, frequently touched surfaces within healthcare settings. Furthermore, Xenex's Chief Executive Officer, Morris Miller, acknowledged the challenges hospitals face when evaluating UV technologies, citing the prevalence of unverified and exaggerated claims by some manufacturers. He underscored the significance of FDA authorization in instilling confidence among hospital decision-makers, assuring them of the accuracy and validation of Xenex's claims regarding the LightStrike+ device. Numerous world-renowned hospitals, such as HonorHealth, Mayo Clinic, MD Anderson Cancer Center, Ochsner Health System, Stanford Health Care, and Texas Health Resources, have integrated LightStrike robots into their comprehensive disinfection strategies. About Xenex Xenex is a global leader in pioneering strategies and solutions grounded in UV technology. Its fundamental mission revolves around enabling its partners to safeguard lives and reduce human suffering by eliminating the dangerous microorganisms that cause infections. The company benefits from substantial support from renowned investors, including EW Healthcare Partners, Piper Sandler, Malin Corporation, Battery Ventures, Targeted Technology Fund II, Tectonic Ventures, and RK Ventures.

Read More